蟾毒灵通过抑制TAM介导的STAT3磷酸化降低结直肠癌细胞PD-L1表达OA
Bufalin reduces PD-L1 expression in colorectal cancer cells through suppressing TAM-mediated STAT3 phosphorylation
目的:探讨蟾毒灵(BU)对肿瘤相关巨噬细胞(TAM)介导的结直肠癌(CRC)细胞程序性死亡蛋白-配体1(PD-L1)表达的调控作用及其分子机制.方法:采用HCT116细胞与THP-1来源巨噬细胞构建体外共培养体系.佛波酯(PMA)诱导THP-1细胞分化为M0型巨噬细胞,进一步以HCT116细胞条件培养基(CM)刺激形成TAM样细胞.流式细胞术检测CD11b、CD206表达,以评价巨噬细胞极化水平;RT-qPCR及WB法检测TGF-β、IL-10、STAT3/p-STAT3及PD-L1表达变化;慢病毒转染构建STAT3敲低细胞系HCT116sh-STAT3,结合BU干预验证STAT3/PD-L1信号通路作用.结果:HCT116细胞CM可诱导巨噬细胞向M2表型极化,表现为CD11b⁺CD206⁺细胞比例升高(P<0.01)及TGF-β、IL-10表达增加(均P<0.001).TAM条件培养基可显著促进HCT116细胞STAT3磷酸化(P<0.001)并上调PD-L1 mRNA及蛋白表达水平(P<0.001或P<0.01).BU干预后,TAM介导的STAT3磷酸化水平明显下降,PD-L1表达同步下调(均P<0.01).STAT3敲低可降低PD-L1表达,其作用趋势与BU一致.结论:BU可通过抑制TAM介导的STAT3信号激活,下调CRC细胞PD-L1表达,提示其在肿瘤免疫微环境调控中具有潜在的应用价值.
Objective:To investigate the regulatory effect of bufalin(BU)on tumor-associated macrophage(TAM)-mediated programmed death-ligand 1(PD-L1)expression in colorectal cancer(CRC)cells and to elucidate the underlying molecular mechanism.Methods:An in vitro co-culture system was established using HCT116 cells and THP-1-derived macrophages.THP-1 cells were differentiated into M0 macrophages by PMA treatment and further stimulated with HCT116-conditioned medium(CM)to generate TAM-like cells.Flow cytometry was used to detect CD11b and CD206 expressions and assess macrophage polarization level.The changes in the expression levels of TGF-β,IL-10,STAT3/p-STAT3,and PD-L1 were detected by RT-qPCR and WB assay.A STAT3 knockdown cell line(HCT116sh-STAT3),constructed by lentiviral transduction,was combined with BU treatment to verify the role of the STAT3/PD-L1 signaling pathway.Results:HCT116-derived CM induced macrophage polarization toward the M2 phenotype,as evidenced by an increased proportion of CD11b⁺CD206⁺ cells(P<0.01)and elevated expression of TGF-β and IL-10(both P<0.001).TAM-conditioned medium significantly promoted STAT3 phosphorylation(P<0.001)and upregulated PD-L1 expression at both mRNA and protein levels in HCT116 cells(P<0.001 or P<0.01).BU treatment markedly suppressed TAM-mediated STAT3 phosphorylation and concomitantly reduced PD-L1 expression(both P<0.01).STAT3 knockdown decreased PD-L1 expression,showing a similar trend to BU treatment.Conclusion:BU downregulates PD-L1 expression in CRC cells by inhibiting TAM-mediated STAT3 signal activation,suggesting its potential application value in regulating the tumor immune microenvironment.
路畅;尚靖;陈进宝;朱媛;钟佳妮;殷佩浩
安徽医科大学 第五临床医学院,安徽 合肥 230022||上海中医药大学附属普陀医院 普外科,上海 200062上海中医药大学附属普陀医院 放射科,上海 200062上海中医药大学附属普陀医院 中医肿瘤科,上海 200062上海中医药大学附属普陀医院 普外科,上海 200062上海中医药大学附属普陀医院 普外科,上海 200062安徽医科大学 第五临床医学院,安徽 合肥 230022||同济大学附属普陀人民医院 普外科,上海 200061
医药卫生
结直肠癌肿瘤相关巨噬细胞程序性死亡配体1HCT116细胞
colorectal cancer(CRC)tumor-associated macrophage(TAM)programmed death-ligand 1(PD-L1)HCT116 cell
《中国肿瘤生物治疗杂志》 2026 (4)
373-378,6
上海市卫生健康系统重点学科(2024ZDXK0044,2024ZDXK0046)上海市普陀区卫生健康系统科技创新项目(ptkwws202409)上海市第六人民医院联合共建科学研究基金(23-LY-03)安徽医科大学研究生科研与实践创新项目(YJS20240117)
评论